Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.91 USD | +1.02% |
|
+4.86% | -8.21% |
06-25 | Oppenheimer Initiates Coverage on Adverum Biotechnologies With Outperform Rating, $25 Price Target | MT |
06-11 | Adverum Biotechnologies, Inc. Announces Executive Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.21% | 143M | |
+16.45% | 122B | |
+21.96% | 116B | |
+24.37% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Transcript : Adverum Biotechnologies, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-15-2020 02